Literature DB >> 27061725

FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers.

Kyle Dyson1, Marie Rivera-Zengotita2, Jesse Kresak1,2, Kristin Weaver1, Brian Stover3, John Fort3, Maryam Rahman1, David W Pincus1, Elias J Sayour1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27061725     DOI： 10.1111/his.12983

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  9 in total

Review 1.  Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics.

Authors:  Erica L Clinkenbeard; Kenneth E White
Journal:  Bone       Date:  2017-01-31       Impact factor: 4.398

2.  Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.

Authors:  Yassine Bouchoucha; Thomas Kergrohen; Alice Métais; Volodia Dangouloff-Ros; Xavier Maynadier; Yassine Ajlil; Matthieu Carton; Wael Yacoub; Raphael Saffroy; Dominique Figarella-Branger; Emmanuelle Uro-Coste; Annick Sevely; Delphine Larrieu-Ciron; Maxime Faisant; Marie-Christine Machet; Ellen Wahler; Alexandre Roux; Sandro Benichi; Kevin Beccaria; Thomas Blauwblomme; Nathalie Boddaert; Fabrice Chrétien; François Doz; Christelle Dufour; Jacques Grill; Marie Anne Debily; Pascale Varlet; Arnault Tauziède-Espariat
Journal:  Acta Neuropathol       Date:  2022-10-20       Impact factor: 15.887

3.  Pediatric midline H3K27M-mutant tumor with disseminated leptomeningeal disease and glioneuronal features: case report and literature review.

Authors:  Ralph E Navarro; Danielle Golub; Travis Hill; Michelle W McQuinn; Christopher William; David Zagzag; Eveline Teresa Hidalgo
Journal:  Childs Nerv Syst       Date:  2020-09-28       Impact factor: 1.475

Review 4.  Emerging glioneuronal and neuronal tumors: case-based review.

Authors:  So Dug Lim; Seong Ik Kim; Jin Woo Park; Jae Kyung Won; Seung-Ki Kim; Ji Hoon Phi; Chun-Kee Chung; Seung-Hong Choi; Hongseok Yun; Sung-Hye Park
Journal:  Brain Tumor Pathol       Date:  2022-01-20       Impact factor: 3.298

5.  Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis.

Authors:  Paul G Ekert; David S Ziegler; Neevika Manoharan; Pamela Ajuyah; Akanksha Senapati; Marie Wong; Anna Mullins; Michael Rodriguez; Helen Doyle; Geoff McCowage; Loretta M S Lau
Journal:  Acta Neuropathol Commun       Date:  2021-09-07       Impact factor: 7.801

6.  Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!

Authors:  Arnault Tauziède-Espariat; Aurore Siegfried; Emmanuelle Uro-Coste; Yvan Nicaise; David Castel; Annick Sevely; Marion Gambart; Sergio Boetto; Lauren Hasty; Alice Métais; Fabrice Chrétien; Joseph Benzakoun; Stéphanie Puget; Jacques Grill; Volodia Dangouloff-Ros; Nathalie Boddaert; Azadeh Ebrahimi; Pascale Varlet
Journal:  Acta Neuropathol Commun       Date:  2022-08-19       Impact factor: 7.578

7.  Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.

Authors:  Anna-Luisa Luger; Sven König; Patrick Felix Samp; Hans Urban; Iris Divé; Michael C Burger; Martin Voss; Kea Franz; Emmanouil Fokas; Katharina Filipski; Melanie-Christin Demes; Albrecht Stenzinger; Felix Sahm; David E Reuss; Patrick N Harter; Sebastian Wagner; Elke Hattingen; Jennifer Wichert; Constantin Lapa; Stefan Fröhling; Joachim P Steinbach; Michael W Ronellenfitsch
Journal:  J Neurooncol       Date:  2022-07-21       Impact factor: 4.506

8.  Clinical progression, pathological characteristics, and radiological findings in children with diffuse leptomeningeal glioneuronal tumors: A systematic review.

Authors:  Haoxiang Jiang; Lu Qiu; Juan Song; Dandan Xu; Lei Sun; Yinbo Feng; Jun Zhao; Jun Qian; Zhiwei Yu; Jin Peng
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

9.  GZD824 overcomes FGFR1-V561F/M mutant resistance in vitro and in vivo.

Authors:  Kaili Jiang; Xia Tang; Jing Guo; Rui He; Shingpan Chan; Xiaojuan Song; Zhengchao Tu; Yuting Wang; Xiaomei Ren; Ke Ding; Zhang Zhang
Journal:  Cancer Med       Date:  2021-06-10       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.